Inventor · disambiguated record
Nicola Cooper
Also filed as: COOPER NICOLA
15 granted patents·7 pending applications·84 citations·filing 2001–2024
93Inventor score
Top patents by PatentIndex Score
22 records- 0196US10525033B2Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2018·Granted Jan 7, 2020·19 cites·26 claims
- 0293US11834478B2Method for the treatment of a relapsing-remitting conditionREVOLO BIOTHERAPEUTICS LTD·Filed 2022·Granted Dec 5, 2023·3 cites·21 claims
- 0393US11479585B2Method for the treatment of a relapsing-remitting conditionREVOLO BIOTHERAPEUTICS LTD·Filed 2018·Granted Oct 25, 2022·11 cites·37 claims
- 0492US8686019B2Use of amisulpride as an anti-emeticGILBERT JULIAN CLIVE·Filed 2012·Granted Apr 1, 2014·13 cites·24 claims
- 0592US2025186394A1Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2024·Application pending·0 cites
- 0691US9889118B2Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2016·Granted Feb 13, 2018·6 cites·20 claims
- 0791US9545426B2Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2015·Granted Jan 17, 2017·7 cites·25 claims
- 0890US9119836B2Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2014·Granted Sep 1, 2015·8 cites·20 claims
- 0989US10085970B2Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2017·Granted Oct 2, 2018·4 cites·19 claims
- 1088US9084765B2Use of amisulpride as an anti-emeticGILBERT JULIAN CLIVE·Filed 2012·Granted Jul 21, 2015·7 cites·33 claims
- 1187US12194022B2Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2023·Granted Jan 14, 2025·0 cites·12 claims
- 1287US11098090B2Mycobacteria tuberculosis chaperonin 60.1 peptides and uses thereofREVOLO BIOTHERAPEUTICS LTD·Filed 2018·Granted Aug 24, 2021·5 cites·11 claims
- 1383US12378291B2Method for the treatment of allergic rhinitisREVOLO BIOTHERAPEUTICS LTD·Filed 2023·Granted Aug 5, 2025·0 cites·21 claims
- 1483US2022296570A1Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2022·Application pending·0 cites
- 1580US2020093792A1Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2019·Application pending·0 cites
- 1675US2021228543A1Use of amisulpride as an anti-emeticACACIA PHARMA LTD·Filed 2020·Application pending·0 cites
- 1769US12331088B2Method for the treatment of a relapsing-remitting conditionREVOLO BIOTHERAPEUTICS LTD·Filed 2022·Granted Jun 17, 2025·0 cites·17 claims
- 1865US9149454B2Use of bethanechol for treatment of xerostomiaCOOPER NICOLA·Filed 2010·Granted Oct 6, 2015·1 cites·10 claims
- 1957US10137084B2Use of bethanechol for treatment of xerostomiaACACIA PHARMA LTD·Filed 2016·Granted Nov 27, 2018·0 cites·16 claims
- 2048US2015366794A1Use of bethanechol for treatment of xerostomiaACACIA PHARMA LTD·Filed 2015·Application pending·0 cites
- 2146US2004248864A1Use of anthroquinones in the treatment of kidney diseaseFiled 2002·Application pending·0 cites
- 2240US2004028734A1Use of anti-muscarinic agents and calcium channel blockers in combinationFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicola Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →